A business in context

EW research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-08 · 0001225208-26-008338

  2. 4 · Ownership change

    Report date 2026-09-11 · 0001225208-26-007812

  3. 4 · Ownership change

    Report date 2026-09-13 · 0001225208-26-007811

  4. 4 · Ownership change

    Report date 2026-09-11 · 0001225208-26-007775

  5. 4 · Ownership change

    Report date 2026-09-11 · 0001225208-26-007774

  6. 4 · Ownership change

    Report date 2026-08-31 · 0001225208-26-007408

  7. 4 · Ownership change

    Report date 2026-08-28 · 0001225208-26-007377

  8. 8-K · Current report

    Report date 2026-08-25 · 0001099800-26-000048 · Items 5.02

  9. 4 · Ownership change

    Report date 2026-08-26 · 0001225208-26-007335

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001099800-26-000043

  11. 8-K · Current report

    Report date 2026-07-23 · 0001099800-26-000038 · Items 2.02,9.01

  12. 8-K · Current report

    Report date 2026-05-07 · 0001099800-26-000028 · Items 5.02,5.07,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001099800-26-000026

  14. 8-K · Current report

    Report date 2026-05-02 · 0001099800-26-000023 · Items 5.02,7.01

  15. 8-K · Current report

    Report date 2026-04-23 · 0001099800-26-000021 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-05-07 · 0001099800-26-000015

  17. 10-K · Annual report

    Report date 2025-12-31 · 0001099800-26-000009

  18. 8-K · Current report

    Report date 2026-02-10 · 0001099800-26-000006 · Items 2.02,9.01

  19. 8-K · Current report

    Report date 2026-01-09 · 0001099800-26-000002 · Items 7.01,9.01

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001099800-25-000062

  21. 8-K · Current report

    Report date 2025-10-30 · 0001193125-25-258662 · Items 5.02,7.01,9.01

  22. 8-K · Current report

    Report date 2025-10-30 · 0001099800-25-000059 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-08-19 · 0001099800-25-000056 · Items 8.01,9.01

  24. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001099800-25-000048

  25. 8-K · Current report

    Report date 2025-08-06 · 0001099800-25-000046 · Items 7.01,9.01

  26. 8-K · Current report

    Report date 2025-07-21 · 0001193125-25-164527 · Items 5.02

  27. 8-K · Current report

    Report date 2025-07-24 · 0001099800-25-000037 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-05-08 · 0001099800-25-000026 · Items 5.02,5.07,9.01

  29. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001099800-25-000023

  30. 8-K · Current report

    Report date 2025-04-23 · 0001099800-25-000020 · Items 2.02,9.01

  31. DEF 14A · Proxy statement

    Report date 2024-12-31 · 0001099800-25-000013

  32. 10-K · Annual report

    Report date 2024-12-31 · 0001099800-25-000005

  33. 8-K · Current report

    Report date 2025-02-11 · 0001099800-25-000003 · Items 2.02,9.01

  34. SC 13G · Ownership disclosure

    0000902219-24-000388

  35. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001099800-24-000086

  36. 8-K · Current report

    Report date 2024-10-24 · 0001099800-24-000084 · Items 2.02,9.01

  37. SC 13G/A · Ownership disclosure

    0000932471-24-000173

  38. 8-K · Current report

    Report date 2024-09-03 · 0001099800-24-000082 · Items 7.01,9.01

  39. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001099800-24-000078

  40. 8-K · Current report

    Report date 2024-07-24 · 0001099800-24-000069 · Items 2.02,7.01,8.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 11 transaction rows11SGrant / award: 4 transaction rows4AExercise / conversion: 10 transaction rows10MTax / exercise payment: 6 transaction rows6FGift: 2 transaction rows2G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

33 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-14
2026-09-14
Markowitz WayneF · Tax / exercise payment
Disposed
Common Stock568.084.37
2026-09-13
2026-09-14
Dahl Andrew M.F · Tax / exercise payment
Disposed
Common Stock253.084.37
2026-09-11
2026-09-14
Markowitz WayneF · Tax / exercise payment
Disposed
Common Stock355.086.77
2026-09-11
2026-09-11
Chopra DaveenF · Tax / exercise payment
Disposed
Common Stock398.086.77
2026-09-11
2026-09-11
Lippis Daniel J.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock619.072.68
2026-09-11
2026-09-11
Lippis Daniel J.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock619.087.51
2026-09-11
2026-09-11
Lippis Daniel J.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (Right to Acquire)
Derivative security
619.00.0
2026-08-31
2026-08-31
Dahl Andrew M.S · Sale
Disposed
Common Stock544.091.06
2026-08-28
2026-08-28
Bruls AnnetteS · Sale
Disposed
Common Stock2644.089.98
2026-08-26
2026-08-26
Chopra DaveenM · Exercise / conversion
Acquired
Common Stock31800.072.68
2026-08-26
2026-08-26
Chopra DaveenS · Sale
Disposed
Common Stock30646.090.99
2026-08-26
2026-08-26
Chopra DaveenS · Sale
Disposed
Common Stock1154.091.76
2026-08-26
2026-08-26
Chopra DaveenM · Exercise / conversion
Disposed
Employee Stock Option (Right to Acquire)
Derivative security
31800.00.0
2026-08-26
2026-08-26
Markowitz WayneS · Sale
Disposed
Common Stock1240.091.47
2026-08-11
2026-08-11
Lippis Daniel J.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock619.072.68
2026-08-11
2026-08-11
Lippis Daniel J.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock619.092.03
2026-08-11
2026-08-11
Lippis Daniel J.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (Right to Acquire)
Derivative security
619.00.0
2026-07-30
2026-07-30
Markowitz WayneS · Sale
Disposed
Common Stock146.3186.03
2026-07-28
2026-07-28
Markowitz WayneM · Exercise / conversion
Acquired
Common Stock9628.074.02
2026-07-28
2026-07-28
Markowitz WayneS · Sale
Disposed
Common Stock9628.085.06
2026-07-28
2026-07-28
Markowitz WayneM · Exercise / conversion
Disposed
Employee Stock Option (Right to Acquire)
Derivative security
9628.00.0
2026-07-27
2026-07-27
Zovighian Bernard JG · Gift
Disposed
Common Stock319.650.0
2026-07-27
2026-07-27
Zovighian Bernard JS · Sale
Disposed
Common Stock2920.5583.93
2026-07-27
2026-07-27
Zovighian Bernard JG · Gift
Acquired
Common Stock319.650.0
2026-07-11
2026-07-13
Bruls AnnetteF · Tax / exercise payment
Disposed
Common Stock109.092.21
2026-07-10
2026-07-10
Lippis Daniel J.
10b5-1 checkbox reported
S · Sale
Disposed
Common Stock619.091.7
2026-07-10
2026-07-10
Lippis Daniel J.
10b5-1 checkbox reported
M · Exercise / conversion
Acquired
Common Stock619.072.68
2026-07-10
2026-07-10
Lippis Daniel J.
10b5-1 checkbox reported
M · Exercise / conversion
Disposed
Employee Stock Option (Right to Acquire)
Derivative security
619.00.0
2026-07-09
2026-07-10
Mistras TheodoraA · Grant / award
Acquired
Common Stock12325.00.0
2026-07-09
2026-07-10
Mistras TheodoraA · Grant / award
Acquired
Common Stock87595.00.0
2026-07-09
2026-07-10
Mistras TheodoraA · Grant / award
Acquired
Employee Stock Option (Right to Acquire)
Derivative security
61800.00.0
2026-07-09
2026-07-10
Mistras TheodoraA · Grant / award
Acquired
Performance Rights
Derivative security
12325.00.0
2026-07-07
2026-07-07
Lippis Daniel J.F · Tax / exercise payment
Disposed
Common Stock377.095.18

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001099800Edwards Lifesciences Corp

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Edwards Lifesciences · alias · wikidata
  • Edwards Lifesciences (Switzerland) · alias · wikidata
  • CVG CONTROLLED INC · former SEC name · 1999-12-08 to 2000-01-21
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$5.44B$5.84B
2023-12-31$5.01B$5.54B
2022-12-31$4.46B$5.14B
2021-12-31$5.23B$6.51B
2020-12-31$4.39B$5.71B
2019-12-31$4.35B$5.73B
2018-12-31$3.72B$5.00B
2017-12-31$3.44B$4.72B

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗